Department of Pediatrics, Kuo General Hospital, Tainan, Taiwan.
J Formos Med Assoc. 2013 May;112(5):269-75. doi: 10.1016/j.jfma.2012.02.011. Epub 2012 May 25.
BACKGROUND/PURPOSE: An increase in group D Salmonella isolates with high antimicrobial resistant rates is being seen in Taiwan. This study aimed to determine the multidrug-resistant (MDR, more than three antibiotics) phenotype, genotype, and the correlation between the presence of class 1 integrons and its invasiveness of Salmonella panama and Salmonella enteritidis isolated from children.
Twenty S. panama and 59 S. enteritidis isolates were examined for minimal inhibitory concentrations of ampicillin, chloramphenicol, streptomycin, sulfonamides, and tetracycline by agar dilution method. The presence of blaPSE-1, floR, aadA2, sul1, and tet(G) resistance genes, class 1 integrons, and Salmonella genomic island 1 (SGI1) was identified by polymerase chain reaction. The adhesion and invasion assays of S. panama to Caco-2 cells were determined using the pour plate method.
All S. panama and 15 (25.4%) of the S. enteritidis isolates displayed MDR phenotype. Furthermore, MDR genotype was present in 70.0% of S. panama and 6.8% of S. enteritidis. Class 1 integrons were present in 40.0% of S. panama and 11.9% of S. enteritidis. None contained SGI1 or SGI1 variants. Strains carrying class 1 integrons were more frequently isolated from bacteria with MDR (73.3% vs. 37.5%; odds ratio, 4.6; 95% confidence interval, 1.3-16.0; p=0.01) and isolated from blood and cerebrospinal fluid (46.7% vs. 21.9%; odds ratio, 3.1; 95% confidence interval, 1.0-10.1; p=0.05) than noncarriers. S. panama carrying class 1 integrons were more invasive to Caco-2 cells than those without (p=0.01).
S. panama and S. enteritidis with class 1 integrons are significantly related to the presence of MDR phenotype. Moreover, S. panama with class 1 integrons may present more invasiveness than those without.
背景/目的:台湾地区分离到的血清型 D 群沙门氏菌的耐药率逐渐升高。本研究旨在检测肠炎沙门氏菌和鼠伤寒沙门氏菌中多重耐药表型、基因型以及与 I 类整合子的存在及其侵袭性之间的相关性。
采用琼脂稀释法检测 20 株肠炎沙门氏菌和 59 株鼠伤寒沙门氏菌对氨苄西林、氯霉素、链霉素、磺胺类药物和四环素的最小抑菌浓度。通过聚合酶链反应检测 blaPSE-1、floR、aadA2、sul1 和 tet(G)耐药基因、I 类整合子和沙门氏菌基因组岛 1(SGI1)的存在。采用倾注平板法检测肠炎沙门氏菌对 Caco-2 细胞的黏附和侵袭能力。
所有肠炎沙门氏菌和 15 株(25.4%)鼠伤寒沙门氏菌均表现出多重耐药表型。此外,70.0%的肠炎沙门氏菌和 6.8%的鼠伤寒沙门氏菌存在多重耐药基因型。40.0%的肠炎沙门氏菌和 11.9%的鼠伤寒沙门氏菌含有 I 类整合子。没有菌株含有 SGI1 或 SGI1 变体。携带 I 类整合子的菌株更常从具有多重耐药性的细菌(73.3%比 37.5%;比值比,4.6;95%置信区间,1.3-16.0;p=0.01)和血液及脑脊液(46.7%比 21.9%;比值比,3.1;95%置信区间,1.0-10.1;p=0.05)中分离到,而不是非携带者。携带 I 类整合子的肠炎沙门氏菌对 Caco-2 细胞的侵袭力高于不携带的菌株(p=0.01)。
携带 I 类整合子的肠炎沙门氏菌和鼠伤寒沙门氏菌与多重耐药表型显著相关。此外,携带 I 类整合子的肠炎沙门氏菌可能比不携带的菌株具有更强的侵袭性。